Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 13, 2018

SELL
$131.06 - $150.39 $543,243 - $623,366
-4,145 Closed
0 $0
Q3 2017

Apr 03, 2018

BUY
$142.62 - $155.6 $264,702 - $288,793
1,856 Added 81.08%
4,145 $606,000
Q3 2017

Nov 15, 2017

BUY
$142.62 - $155.6 $85,999 - $93,826
603 Added 35.77%
2,289 $335,000
Q2 2017

Sep 20, 2017

SELL
N/A
-1,043 Reduced 38.22%
1,686 $237,000
Q1 2017

Sep 20, 2017

BUY
N/A
2,729
2,729 $389,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.76B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Level Four Advisory Services, LLC Portfolio

Follow Level Four Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Level Four Advisory Services, LLC with notifications on news.